Vendor source

Reviewed 11 May 2026

Completeness Strong (72%)

Neurocloud PET

Qubiotech

Neurocloud PET for quantitative brain PET image analysis provides neurology and nuclear medicine professionals with automatic assistance in the diagnosis and monitoring of neurodegenerative diseases. - FDG PET imaging: identifies regions with abnormal metabolism by comparative analysis against an extensive database of normals, stratified by age. An analysis based on regions of interest, asymmetries and parametric statistical analysis (voxel by voxel) is performed. - Amyloid PET imaging: provides SUVR values and outcome (amyloid positive/negative) compared to validated thresholds.

Supported by 4 papers

Key Features

  • Customizable report
  • Identify and quantify regions with abnormal metabolism
  • Positive/negative amyloid result

General Information

Product name

Neurocloud PET

Company

Modality

MR, PET

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Alzheimer's disease (AD), Parkinson's disease, dementia, epilepsy, encephalitis

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

18F-FDG 3D iterative reconstruction (mandatory), florbetaben, flutemetamol, flobetapiR, MRI T1 3D (optional)

Input format

DICOM

Output

Color image overlay, ROI analysis, asymmetries, parametric statistical analysis (voxel by voxel), SUVR calculation, positive/negative amyloid result, automatic quantification customizable report

Output format

DICOM, EXCEL, NIFTI, PDF

Integration

Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

Patients from 9 to 89 yo

Market Presence

On market since

09-2017

AI Platforms

Alma Health Platform

Resellers

Not specified

Countries present

3

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Customizable plans, Subscription

Based on

Customizable plans, Number of analyses, Number of installations

Source: Vendor | First published: Sep 10, 2023 | Last updated: May 11, 2026

Neurocloud PET - Qubiotech